Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma (Q36988067)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 June 2010
edit
Language Label Description Also known as
English
Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma
scientific article published on 10 June 2010

    Statements

    Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma (English)
    Jimmy J Hwang
    John Kuruvilla
    David Mendelson
    Michael J Pishvaian
    J F Deeken
    Lillian L Siu
    Mark S Berger
    Jean Viallet
    John L Marshall
    10 June 2010
    4038-4045

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit